(19)
(11) EP 1 062 319 A1

(12)

(43) Date of publication:
27.12.2000 Bulletin 2000/52

(21) Application number: 99912320.1

(22) Date of filing: 10.03.1999
(51) International Patent Classification (IPC)7C12N 1/21, C12N 5/10, C12N 15/18, C12N 15/63, C12Q 1/00, C12Q 1/68, C12Q 1/70, A61K 38/18, C07K 14/50, C07K 16/22
(86) International application number:
PCT/US9905/021
(87) International publication number:
WO 9946/364 (16.09.1999 Gazette 1999/37)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 13.03.1998 US 42105
30.06.1998 US 107997

(71) Applicant: HUMAN GENOME SCIENCES, INC.
Rockville, MD 20850-3338 (US)

(72) Inventors:
  • ROSEN, Craig, A.
    Laytonsville, MD 20882 (US)
  • CAO, Liang
    Hong Kong (CN)
  • HU, Jing-Shan
    Sunnyvale, CA 94086 (US)

(74) Representative: VOSSIUS & PARTNER 
Siebertstrasse 4
81675 München
81675 München (DE)

   


(54) VASCULAR ENDOTHELIAL GROWTH FACTOR 2